These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30537552)

  • 1. The Role of Salvage Second Autologous Hematopoietic Cell Transplantation in Relapsed Multiple Myeloma.
    Hagen PA; Stiff P
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):e98-e107. PubMed ID: 30537552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
    Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
    Garderet L; Iacobelli S; Koster L; Goldschmidt H; Johansson JE; Bourhis JH; Krejci M; Leleu X; Potter M; Blaise D; Koenecke C; Peschel C; Radocha J; Metzner B; Lenain P; Schäfer-Eckart K; Pohlreich D; Grasso M; Caillot D; Einsele H; Ladetto M; Schönland S; Kröger N
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1372-1378. PubMed ID: 29408334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
    Cook G; Ashcroft AJ; Cairns DA; Williams CD; Brown JM; Cavenagh JD; Snowden JA; Parrish C; Yong K; Cavet J; Hunter H; Bird JM; Pratt G; Chown S; Heartin E; O'Connor S; Drayson MT; Hockaday A; Morris TC;
    Lancet Haematol; 2016 Jul; 3(7):e340-51. PubMed ID: 27374467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to recommend a second autograft in patients with relapsed myeloma?
    Ziogas DC; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2017 Apr; 58(4):781-787. PubMed ID: 27894207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan.
    Muta T; Miyamoto T; Kamimura T; Kanda Y; Nohgawa M; Ueda Y; Iwato K; Sasaki O; Mori T; Uchida N; Iida S; Fukuda T; Atsuta Y; Sunami K
    Acta Haematol; 2018; 139(1):35-44. PubMed ID: 29339642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival.
    Jimenez-Zepeda VH; Mikhael J; Winter A; Franke N; Masih-Khan E; Trudel S; Chen C; Kukreti V; Reece DE
    Biol Blood Marrow Transplant; 2012 May; 18(5):773-9. PubMed ID: 22062804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
    Mark TM; Guarneri D; Forsberg P; Rossi A; Pearse R; Perry A; Pekle K; Tegnestam L; Greenberg J; Shore T; Gergis U; Mayer S; Van Besien K; Ely S; Jayabalan D; Sherbenou D; Coleman M; Niesvizky R
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):930-937. PubMed ID: 28285081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients.
    Sellner L; Heiss C; Benner A; Raab MS; Hillengass J; Hose D; Lehners N; Egerer G; Ho AD; Goldschmidt H; Neben K
    Cancer; 2013 Jul; 119(13):2438-46. PubMed ID: 23576287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft.
    Gössi U; Jeker B; Mansouri Taleghani B; Bacher U; Novak U; Betticher D; Egger T; Zander T; Pabst T
    Hematol Oncol; 2018 Apr; 36(2):436-444. PubMed ID: 29363149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.
    Gay F; Engelhardt M; Terpos E; Wäsch R; Giaccone L; Auner HW; Caers J; Gramatzki M; van de Donk N; Oliva S; Zamagni E; Garderet L; Straka C; Hajek R; Ludwig H; Einsele H; Dimopoulos M; Boccadoro M; Kröger N; Cavo M; Goldschmidt H; Bruno B; Sonneveld P
    Haematologica; 2018 Feb; 103(2):197-211. PubMed ID: 29217780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second autologous transplant as salvage therapy in multiple myeloma.
    Atanackovic D; Schilling G
    Br J Haematol; 2013 Dec; 163(5):565-72. PubMed ID: 24111632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there still a role for stem cell transplantation in multiple myeloma?
    Mina R; Lonial S
    Cancer; 2019 Aug; 125(15):2534-2543. PubMed ID: 30985927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy.
    Rocchi S; Zannetti BA; Marconi G; Lanza F
    Cells; 2024 May; 13(10):. PubMed ID: 38786075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous stem cell transplantation: an effective salvage therapy in multiple myeloma.
    Lemieux E; Hulin C; Caillot D; Tardy S; Dorvaux V; Michel J; Gastinne T; Rossi C; Legouge C; Touzeau C; Planche L; Loirat M; Lafon I; Moreau P
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):445-9. PubMed ID: 23186983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of relapsed multiple myeloma after autologous stem cell transplant.
    Holstein SA; Richardson PG; Laubach JP; McCarthy PL
    Biol Blood Marrow Transplant; 2015 May; 21(5):793-8. PubMed ID: 25652690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The guidelines for the diagnosis and management of multiple myeloma in China(2020 revision)].
    ; ;
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):341-346. PubMed ID: 32370461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.
    Chavda SJ; Maciocia PM; Mesiri P; Counsell N; Kothari J; Bird A; Mariner C; Chew A; Clesham K; Moore S; Percy L; Rismani A; D'Sa S; Rabin N; Popat R; Yong K
    Br J Haematol; 2019 Apr; 185(2):350-353. PubMed ID: 29984833
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
    Zheng D; Li J; Huang BH; Liu JR; Zou WY; Su C
    Chin Med J (Engl); 2012 Dec; 125(24):4454-9. PubMed ID: 23253719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.
    Garfall AL; Stadtmauer EA; Hwang WT; Lacey SF; Melenhorst JJ; Krevvata M; Carroll MP; Matsui WH; Wang Q; Dhodapkar MV; Dhodapkar K; Das R; Vogl DT; Weiss BM; Cohen AD; Mangan PA; Ayers EC; Nunez-Cruz S; Kulikovskaya I; Davis MM; Lamontagne A; Dengel K; Kerr ND; Young RM; Siegel DL; Levine BL; Milone MC; Maus MV; June CH
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.